India's Panacea Biotec to produce 100 mln Sputnik V doses annually -RDIF
- Country:
- Russian Federation
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
ALSO READ
-
Inside Russia’s SMR School, Where Nuclear Experience Shapes Future Energy Decisions
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
Russia’s Reach Beyond Borders Leaves Exiled Critics Living in Fear, UN Expert Warns
-
Ukraine Faces Another Bitter Winter as UN Inquiry Warns of Deepening Civilian Harm
-
Ukraine War: UN Documents 1,004 Sexual Violence Cases and Calls for Justice
Google News